©2018 Shenzhen Foncoo Pharmaceutical Co., Ltd.,Legal notices | Copyright Notice  | Contact us | links
粤ICP备13052717号-1 | 粤-非经营性-2018-0343



The 2019 Foncoo Pharmaceutical Agency Meeting Concluded

Hot news

Current opinion in psychiatry An international review journal
Foncoo Company Participated in the Fifth Xiangya Psychiatric International Forum and Held Seminar
Review of “Red Lines for Enterprises”: Eight Disciplines Obeyed by Foncoo Pharmaceutical in Building “Incorruptible Culture”
Attending 15th Annual Meeting of Chinese Psychiatrist Association and Holding a Special Meeting
Annual Work Summary & Commendation Meeting of Foncoo Pharmaceutical Convened Smoothly

The 2019 Foncoo Pharmaceutical Agency Meeting Concluded

Page view

On December 14, 2019, Foncoo Pharmaceutical annual agent meeting was held in Shenzhen and a total of 25 agents of Olanzapine were invited to participate in the meeting. Qin Cheng, chairman of Foncoo, Mr. Fu Qun, deputy general manager of Foncoo, Mr. Qian Fangping, marketing director of Foncoo, Ms. Yan Xiaohui, financial director of Foncoo and other leaders of Foncoo attended the meeting.


Mr. Qin Cheng made a keynote speech entitled "Customer First". He first reviewed the sales and market performance of Olanzapine in 2019, expressed his sincere gratitude to all agents of Olanzapine. Looking forward to the future, he hoped to grasp more opportunities and worked together with all partners to create a better future together. Ms. Luo Jianying, partner of KPMG China Tax Service, was invited to give a special speech on "2019 Tax Administration Environment and Response to Inspection” and three representative provinces were invited to share their cases. Finally, the company gave awards to outstanding agents.



Contact us

  • Shenzhen Foncoo Pharmaceutical Co., Ltd.
  • Tel:+86-0755-82873500
  • Fax:+86-0755-82873511
  • Hotline:+86-0755-82873505
  • Add:Unit 701,Block A,Guoren Building,Keji Middle 3rd Road,Hi-Tech Park,Nanshan District,Shenzhen,China.